Posted on 10/28/20
Eucrates Biomedical Acquisition Corp. Closes $100M IPO
Eucrates Biomedical Acquisition Corp., a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar . . .
Posted on 10/28/20
Citius Pharmaceuticals Issues October 2020 Letter to Shareholders
Citius Pharmaceuticals, Inc. (NASDAQ: CTXR), a specialty pharmaceutical company developing and commercializing critical care drug products, announced that it has issued an October 2020 Letter to Shareholders. . . .
Posted on 10/28/20
PDV Health Consulting Announces Launch of New Healthcare Consultant Firm
PDV Health Consulting recently announced its official launch. Established by Paul D. Vitale, a healthcare industry leader for over 35 years, PDV Health Consulting (PDVHC) is . . .
Posted on 10/28/20
Getting a Good Night’s Sleep in Troubled Times
On Sunday, November 1st, at 2 am, clocks will be turned one hour back for Daylight Savings Time, so when the clock reads 10 am on . . .
Posted on 10/27/20
WebMD Health to Acquire coliquio
WebMD Health Corp., an Internet Brands company and a leader in health information services for physicians, other healthcare professionals and consumers, today announced that it has . . .
Posted on 10/27/20
Pfizer Reports Third-Quarter 2020 Results
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) reported financial results for third-quarter 2020 and updated and tightened certain components of Total Company(3) 2020 financial guidance, which continues . . .
Posted on 10/27/20
Merck Announces Third-Quarter 2020 Financial Results
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the third quarter of 2020.“We continue to . . .
Posted on 10/27/20
Acorda Third Quarter 2020 Update
ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (NASDAQ: ACOR) will host a conference call and webcast in conjunction with its third quarter 2020 update and financial results on . . .
Posted on 10/27/20
Cerberus Acquires National Dentex Labs
Cerberus Capital Management, L.P., a global leader in alternative investing, today announced that one of its affiliates has acquired National Dentex Labs
Posted on 10/27/20
MultiPlan Corporation Prices of Senior Notes
NEW YORK--(BUSINESS WIRE)--MultiPlan Corporation (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management solutions to the U.S. healthcare industry, today announced that . . .
Posted on 10/26/20
NephCure Kidney International Celebrates 20th Anniversary with Special Countdown to a Cure Event
The organization’s largest event of the year will be heldvirtually for the first time in history NephCure Kidney International (NephCure), a nonprofit dedicated to finding cures . . .
Posted on 10/26/20
New 2020 Children’s Mental Health Report and Telehealth Survey Results
The Child Mind Institute today released the 2020 Children’s Mental Health Report: Telehealth in an Increasingly Virtual World, a new analysis of the impact telehealth is . . .
Posted on 10/26/20
New Mountain Capital to Acquire Natrol from Aurobindo Pharma
NEW YORK--(BUSINESS WIRE)--New Mountain Capital announced that it has reached a definitive agreement with Aurobindo Pharma to acquire Natrol and combine it with Jarrow Formulas, another . . .
Posted on 10/26/20
MultiPlan Corporation Offers Senior Notes
NEW YORK--(BUSINESS WIRE)--MultiPlan Corporation (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management solutions to the U.S. healthcare industry, today announced that . . .
Posted on 10/26/20
Lux Health Tech Acquisition Corp. Launch of $300 Million IPO
NEW YORK--(BUSINESS WIRE)--Lux Health Tech Acquisition Corp. announced today that it has commenced its initial public offering of 30,000,000 units at a price of $10.00 per . . .
Posted on 10/26/20
Jazz Pharmaceuticals Acquires SpringWorks Therapeutics
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and SpringWorks Therapeutics, Inc. (Nasdaq: SWTX) today announced that Jazz Pharmaceuticals Ireland Limited and SpringWorks
Posted on 10/26/20
Bayer Acquires Asklepios BioPharmaceutical
Bayer AG today announced the acquisition of Asklepios BioPharmaceutical, Inc. (AskBio), a US-headquartered biopharmaceutical company specialized in the research, development a
Posted on 10/26/20
Pfizer Stock: Headed to $42?
Pfizer (NYSE:PFE) has had its ups and downs as a company, but one prognosticator thinks it's got more of the former than the latter coming up. . . .
Posted on 10/23/20
Gracie Square Hospital Raises Awareness during October: National Depression and Mental Health Screening Month
Depression is one of the most common mental health disorders, but the pandemic has increased the number of adults struggling with symptoms. In fact, data from a . . .
Posted on 10/23/20
Eucrates Biomedical Acquisition Prices of $100 Million IPO
Eucrates Biomedical Acquisition Corp., a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar . . .
Posted on 10/23/20
Here's Why Quest Diagnostics Made Investors Happy With Its Q3 Results
Quest Diagnostics (NYSE:DGX) has taken investors on a roller-coaster ride so far in 2020. But the ride has been a fun one over the last couple . . .
Posted on 10/23/20
Is Regeneron a Buy Before Nov. 3?
Regeneron Pharmaceuticals (NASDAQ:REGN) made headlines recently after President Trump, diagnosed with COVID-19 earlier this month, took the biotech's investigational treatment. Trump, who also took other experimental . . .
Posted on 10/22/20
Quest Diagnostics Reports Third Quarter 2020 Financial Results
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the third quarter ended September 30, 2020."Quest had . . .
Posted on 10/22/20
Antares Pharma to Report Third Quarter 2020 Financial and Operating Results
EWING, N.J., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) a pharmaceutical technology company, today announced it will release its third quarter 2020 . . .
Posted on 10/21/20
Phreesia Prices of Public Offering of Common Stock
NEW YORK--(BUSINESS WIRE)--Phreesia, Inc. (NYSE:PHR), a leading patient intake management platform, announced today the pricing of its previously announced underwritten public offering of 5,000,000 shares of . . .
New York
